COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.

ABSTRACT:

SUBMITTER: Morales-Ortega A 

PROVIDER: S-EPMC8250378 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature